Types of Manuscripts
The following types of manuscripts are published in Edorium Journal of Pathology:
Research Article
Clinical Studies
Short Report
Rapid Communication
Technical Report
Protocols
Case Series
Case Report
Clinical Images
Letter to Editors
Review Article
Editorial
Research Articles
Research articles report results of original research study. The study should describe the methodology in detail and discuss the results.
Authors: Any number of authors
Abstract: Structured abstract less than 250 words (Aims, Methods, Results, Conclusion)
Keywords: 3-5
Word limit: No word limit
Structure of manuscript: Introduction, Materials and Methods, Results, Discussion, Conclusion
Tables: Any number
Figures: Any number
References: 100 or less
Clinical Studies
A clinical study reports results of results of a study performed within a clinical setting. These studies include randomized controlled trials, interventional studied, case-control studies, retrospective studies, outcome studies, studies of screening and diagnostic test and cost effectiveness analyses. The clinical studies should include a description of the patient group.
Authors: Any number of authors
Abstract: Structured abstract less than 250 words (Aims, Methods, Results, Conclusion)
Keywords: 3-5
Word limit: No word limit
Structure of manuscript: Introduction, Materials and Methods, Results, Discussion, Conclusion
Tables: Any number
Figures: Any number
References: 100 or less
Short Reports
Short Reports will present exciting findings that will have a major impact in genetics and gene therapy science. Short Reports will describe completed work on significant novel developments or important preliminary observations, therapeutic advances and any significant scientific or clinical observations.
Authors: Six authors maximum
Abstract: Structured abstract less than 250 words (Aims, Methods, Results, Conclusion)
Keywords: 3-5
Word limit: Less than 4000 words
Structure of manuscript: Introduction, Materials and Methods, Results, Discussion, Conclusion
Tables: 5 or less
Figures: 10 or less
References: 30 or less
Rapid Communication
This section will present preliminary, yet novel and exciting findings. These manuscripts will undergo quick peer review and will be considered for fast track publication. Decision about acceptance under "Rapid Communication" category will be communicated to the authors quickly. If the paper is not found suitable for Rapid Communication, authors will be asked whether they agree to have their paper reclassified as a "Short Report".
Authors: Six authors maximum
Abstract: Structured abstract less than 250 words (Aims, Methods, Results, Conclusion)
Keywords: 3-5
Word limit: Less than 4000 words
Structure of manuscript: Introduction, Materials and Methods, Results, Discussion, Conclusion
Tables: 5 or less
Figures: 10 or less
References: 30 or less
Technical Reports
Technical Reports describe a new experimental or computational method, test or procedure (basic science or clinical) including new study methods, modifications to existing methods or innovative applications of existing methods
Authors: Six authors maximum
Abstract: Structured/unstructured abstract less than 250 words
Keywords: 3-5
Word limit: Less than 4000 words
Structure of manuscript: Introduction, Other headings as required by the topic
Tables: 5 or less
Figures: 10 or less
References: 30 or less
Protocols
Protocols can be for any study design, including epidemiological studies and systematic reviews. All protocols for randomized clinical trials must be registered. Ethical approval for the study must have been already granted.
Authors: Six authors maximum
Abstract: Structured/unstructured abstract less than 250 words
Keywords: 3-5
Word limit: Less than 4000 words
Structure of manuscript: Introduction, Other headings as required by the topic
Tables: 5 or less
Figures: 10 or less
References: 30 or less
Case Series
The Case Series section reports a series of 2-6 similar cases. The cases should address a challenging diagnostic and/or therapeutic problem with possible solutions to help clinicians in managing these cases. Case series must be accompanied with a comprehensive review of literature.
Authors: Six authors maximum
Abstract: Structured abstract less than 250 words (Introduction, Case Series, Conclusion) or unstructured abstract less than 250 words following the general pattern of a structured abstract
Keywords: 3-5
Word limit: Less than 4000 words
Structure of manuscript: Introduction, Case Series, Discussion, Conclusion
Tables: 5 or less
Figures: 10 or less
References: 30 or less
Case Report
Case Reports must provide an original description of a previously unreported entity or report new presentation of a known disease or a new perspective of case which poses a diagnostic and therapeutic challenge. Case Reports should include a comprehensive review of literature.
Authors: Six authors maximum
Abstract: Structured abstract less than 250 words (Introduction, Case Report, Conclusion) or unstructured abstract less than 250 words following the general pattern of a structured abstract
Keywords: 3-5
Word limit: 4000 words maximum
Structure of manuscript: Introduction, Case Report, Discussion, Conclusion
Tables: 5 or less
Figures: 10 or less
References: 30 or less
Clinical Images
Clinical Images section includes clinical images, diagnostic or investigative images especially images in radiology, endoscopy, pathology and cytopathology. The images should be accompanied by a brief history and case discussion followed by a conclusion. Abstract is not required. The Clinical Images will undergo peer review similar to other articles.
Authors: Four authors maximum
Abstract: Not required
Keywords: 3-5
Word limit: Less than 2000 words
Structure of manuscript: Case Report, Discussion, Conclusion
Tables: 2 or less
Figures: 5 or less
References: 15 or less
Letters to the Editor
This section accepts manuscripts which report unique cases but do not qualify for other sections, results of pilot studies and comment on the articles published in the journal. An abstract is not required. The letter should not be divided into sections.
Authors: Four authors maximum
Abstract: Not required
Keywords: 3-5
Word limit: 1500 words maximum
Structure of manuscript: Start the manuscript as 'To the Editors'. Do not divide the manuscript into sections.
Tables: 1 or less
Figures: 2 or less
References: 15 or less
Review Articles
Review articles should have a comprehensive coverage of a topic in a clear and lucid language with representative figures and images. Authors can submit the articles directly to the journal or they may discuss their proposal before writing. To discuss a proposal please contact the Managing Editor through the "Contact Editorial Office" page or send an email to the Managing Editor.
Authors: Six authors maximum
Abstract: Unstructured abstract less than 250 words
Keywords: 3-5
Word limit: Less than 5000 words
Structure of manuscript: Introduction, Other headings as required by the topic
Tables: 10 or less
Figures: 20 or less
References: 100 or less
Manuscript Organization
Organize the manuscript as given below, in order:
Title Page
Abstract
3-5 Keywords
Manuscript Text
Conflict of Interest
Author's Contribution
Acknowledgements
References
Tables
Graphs/Charts
Figure Legends
General Guidelines
Start main text of the manuscript on a page separate from the abstract page.
Use a normal, plain font for text (e.g. 12-14 point Times New Roman).
Manuscripts should be double-spaced.
There should be at least one inch margin all around the text.
Number the pages consecutively, starting from the title page.
Use hard returns at the end of paragraphs, do not use an extra hard return after each line.
Do not use abbreviations in the title or abstract.
Cover Letter
Every submission must be accompanied by two essential files - COVER LETTER and MANUSCRIPT TEXT FILE.
Include the following in the Cover Letter:
Title of the manuscript
Section to which the manuscript is being submitted e.g. Review Article, Original Article, Case Report etc.
Include in the cover letter - the full name, affiliation, academic degree(s) and email addresses of all authors.
The cover letter should be signed by the corresponding author on behalf of all the authors.
The name of the corresponding author with contact address, contact phone number, email and fax number (if available) must be clearly listed.
We encourage you to use the Cover Letter Template for drafting your cover letter. You can replace the dummy text in red font with your manuscript details.
Click here to download the Cover Letter Template.
Title Page
The first page of the manuscript the 'Title Page' should include the following:
Type of manuscript (Original Articles, Clinical Studies, Short Reports, Rapid Communication, Technical Reports, Protocols, Case Series, Case Reports, Clinical Images, Letter to the Editors, Review Articles and Editorial)
Title of manuscript (No abbreviations in the title)
First Name and Surname of all authors
Highest academic qualification (e.g. M.D.)
Academic position in the department
Author affiliations (department, institution, city, state, country). Link author names to respective institutions by using superscript Arabic numerals.
Name of corresponding author with contact address, contact phone number, email and fax number
Include the statement - "Guarantor of Submission - The corresponding author is the Guarantor of Submission"
Short running title of the manuscript (less than 40 characters).
The corresponding author is considered the guarantor for the integrity of the manuscript as a whole. If authors want to designate anyone other than the corresponding author as the guarantor of submission, mention his/her name on the title page with contact address, contact phone number, email and fax number.
Abstract with Keywords
Abstract should start on a new page after the Title Page. The abstract must not exceed 250 words for any type of article.
Structure the abstract as given below:
Original Articles - Aims, Methods, Results, Conclusion
Clinical Studies - Aims, Methods, Results, Conclusion
Short Reports - Aims, Methods, Results, Conclusion
Rapid Communication - Aims, Methods, Results, Conclusion
Technical Reports – Structured/unstructured abstract
Protocols - Structured/unstructured abstract
Case Series - Structured (Introduction, Case Report, Conclusion) or unstructured abstract
Case Reports - Structured (Introduction, Case Report, Conclusion) or unstructured abstract
Clinical Images - Abstract not required
Letters to Editors - Abstract not required
Review Article - Unstructured abstract (less than 250 words)
Editorial - Abstract not required
The sections in the abstract should briefly describe objectives of the study, the procedures followed, the main findings with statistical significance and the main conclusions.
Provide 3 to 5 keywords below the abstract, which will be used for indexing purposes.
Do not list anything in the abstract that is not in the manuscript.
Do not include references in abstract.
Introduction
In this section clearly state the purpose of the study or experiment and summarize the rationale for the study or observation.
Give here only pertinent references.
Do not review the subject extensively.
Do not include data or conclusions from the work being reported in the paper.
Materials and Methods
Give here only the information included in the plan or protocol of the study, before the data collection or patient recruitment was started. Any information or data collected during the study period should be presented in the Results section.
Describe the criteria used for selecting observational or experimental subjects. Give the number of subjects in each study group with details about randomization. Describe the methods used for blinding of observations.
Identify the methods, apparatus, equipment, reagents, and procedures used in sufficient detail to allow other colleagues to reproduce the results. When a reagent, an apparatus or any equipment is mentioned for the first time in the text, provide in parenthesis the model name or number, manufacturer's name and location. Identify precisely all drugs and chemicals used, including generic name(s), dose(s) and route(s) of administration.
Avoid any details which might identify the patient(s) unless absolutely necessary. If identification of patient(s) is unavoidable, informed consent must be obtained from the patient and submitted to the Editorial Office.
All manuscripts dealing with recombinant DNA research must indicate the physical and biologic containment procedures practiced, in accordance with the Health Guidelines for Research Involving Recombinant DNA Molecules established by the National Institutes of Health.
All randomized controlled trials submitted for publication should present information on the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups) and the method of masking (blinding). Include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart with all manuscripts. Please refer to the CONSORT statement website at http://www.consort-statement.org for more information.
To view the Standards of Reporting for various studies, click here.
Statistical Analysis
Put in a separate paragraph, in the Materials and Methods section, a general description of the statistical methods used.
Specify the statistical methods used to analyze different variables. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals).
For all P values include the exact value and not less than 0.05 or 0.001.
References for study design and statistical methods should be to standard works when possible.
Specify any software/computer program used for analyzing data.
Results
Present the results in logical sequence using text, tables, figures, images and graphs.
Report losses to observation (such as dropouts from a clinical trial).
Report treatment complications.
Specify the numbers of observations.
Do not repeat in the text any data presented in tables and/or illustrations.
Present the numeric data both as the absolute numbers and as derivatives (e.g. percentages) and specify the statistical methods used to analyze them.
Use graphs as an alternative to tables with many entries.
Discussion
Include a summary of key findings in the first paragraph of 'Discussion' section.
Give a comprehensive review of literature.
Emphasize the new and important aspects of the study and the conclusions that follow from them.
Include in the 'Discussion' the interpretation and implications of the findings and future research directions. Recommendations, when appropriate, may be included.
Give the strengths and limitations of the study (study question, study design, data collection, analysis and interpretation).
Do not repeat in detail, data or other material given in the 'Introduction' or 'Results' section or tables and figures.
Avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses.
State new hypotheses when warranted, but clearly label them as such.
Conclusion
Conclusion should highlight the main points learnt from the case in a short paragraph of 3-4 sentences.
For Case Series and Case Reports only
In the Case Series/Case Report section in both type of manuscripts, give all the relevant details about the case(s).
Describe the patient's present and past medical history; presenting symptoms and signs; results of laboratory tests, description of any treatment or intervention.
Illustrate the case with figures, images and tables.
List of Abbreviations
If abbreviations are used in the text, either they should be defined in the text when first used or a list of abbreviations can be provided before the references.
Conflict of Interest
All authors must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript or a competing product to the one mentioned in the manuscript and/or is important to the outcome of the study presented.
All funding sources supporting the work, and institutional or corporate affiliations of the author(s), should be acknowledged here.
All conflict of interests will be listed at the end of the published article. If the author(s) gives no conflict of interests, the following sentence will be used - 'The author(s) declare no conflict of interests'.
Authors Contribution
The individual contribution of all the authors to the work described in the manuscript will be published with the article.
Once the manuscript is submitted, the order of authors cannot be changed without written consent from all the authors.
All contributors who do not meet the criteria for authorship should be listed in the acknowledgements section.
Acknowledgements
In this section acknowledge anyone who contributed towards the study by making contributions like arranging for funds, general supervision or contribution of materials essential for the study or technical assistance. Authors must obtain permission from all persons mentioned in this section to acknowledge them.
If text and/or figures are being reprinted with the permission of an author or publisher, acknowledge them in this section.
References
Authors of the manuscript are responsible for the accuracy of references.
All references in text, tables, and legends must be identified by consecutive Arabic numerals in square brackets, listed immediately before the closing punctuation mark. E.g. [1] or [1, 2] or [1-4] or [1-4, 6] or [1, 2, 5-7] or [1, 4-5, 8, 11-16]
Any reference that is cited only in the tables or figure legends should be numbered according to the first identification of the table or figure in the main text in continuation with the sequence of citation numbering. For example:
If the last reference cited before the first citation of Figure 1 is reference [20], and the Figure 1 legend contains a reference cited only in the Figure 1 legend, that reference should be numbered as [21], and the next reference cited in the main text would be [22].
If the last reference cited before the first citation of Table 2 is reference [34], and the Table 2 legend contains a reference cited only in the Table 2 legend, that reference should be numbered as [35], and the next reference cited in the main text would be [36].
Place the references in square brackets, immediately after the author name or if author name is not included in the sentence, at the end of the sentence before the closing punctuation mark.
In the 'Reference' section, number each reference consecutively in the order in which they are first mentioned in the text (not in alphabetic order).
Each reference must have a reference number.
References should not be used in titles or headings.
List all authors up to 6; if more than 6, list the first 6 followed by 'et al.'
Abbreviate the journal titles according to the style used in Index Medicus/PubMed.
Use complete journal names for non-indexed journals.
Avoid using abstracts as references.
Avoid citing unpublished data or manuscripts, personal communications, web sites, conference papers and non-peer reviewed publications.
Avoid citing text books as references and very old references.
If personal communication is cited, it should be listed at the appropriate location in the text, in parenthesis, after punctuation. Do not include it as a reference. For personal communications include the following in parenthesis - name of individual, highest academic qualification, institute, country, year in which the information was obtained and whether it was oral or written communication. Authors who cite personal communications must obtain written permission from all cited individuals.
Please take extreme care in following the reference style given below. Manuscripts with references not formatted in the correct style will be returned to the authors for revision before being sent for Editorial Review.
References must follow the general arrangement and punctuation outlined in International Committee of Medical Journal Editors Uniform requirements for manuscripts submitted to biomedical journals. Ann Intern Med, 1988;108:258-265 or Br Med J. 1988;296:401-405.
References should be typed, double-spaced, after the acknowledgements. Provide inclusive page numbers for all references.
The general format of the references is:
Author Surname followed by Initials. Article title. Abbreviated journal name year;volume(number):inclusive page numbers.
No space between - year;volume(number):inclusive page numbers.
Example of Edorium Journal of Pathology reference style are shown below.
Article within a journal
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;3(4):19–22.
Web Links
Online-only Articles
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology [serial online] 2012; vol 3, no. 4. Available at: www.ijcasereportsandimages.com/archive/2012/004-2012-ijcri/005-04-2012-winter/ijcri-00504201255-winter-full-text.php. Accessed June 22, 2010.
Volume with supplement
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;3Suppl 1:19–22.
Issue with supplement
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;3(4,Suppl 3):19–22.
Organization as author
Edorium Journals Group. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;3(4):196–98.
Both personal authors and an organization as author
Winter H, Field M, McDaid J, Vishwanath D, Inston N; for Edorium Journals Study Group. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;3(4):298-306.
Volume with no issue
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;3:19–22.
Issue with no volume
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;(4):19–22.
No volume or issue
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012:19–22.
Article published electronically ahead of the print
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology 2012;3(4):19–22. Epub 2012 Jan 6
Article in other language
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma (In French). Edorium Journal of Pathology 2012;3(4):19–22.
Article in other language with English abstract
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma (In French with English abstract). Edorium Journal of Pathology 2012;3(4):19–22.
In press article
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. Edorium Journal of Pathology , In press.
Published abstract
Winter H, Field M, McDaid J, Vishwanath D, Inston N. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma [abstract]. Edorium Journal of Pathology 2012;3(4):s261.
Article within conference proceedings
Winter H, Field M, McDaid J. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. In proceedings of the First Edorium Journals International Conference: 21-24 July 2011; New York. Edited by H. Winter: Edorium Journals;2012:210-14.
Conference proceedings
Winter H, Field M, McDaid J. Primary hyperparathyroidism presenting as paraneoplastic syndrome in a patient with renal cell carcinoma. In proceedings of the First Edorium Journals International Conference: 21-24 July 2011; New York, USA. London: EdoriumJOurnals; 2012
Book
Winter H, Field M, McDaid J. Primary hyperparathyroidism diagnosis and management, 3ed. New York: Edorium Journals; 2012. p. 26-31.
Book chapter
Winter H, Field M, McDaid J. Primary hyperparathyroidism presenting as paraneoplastic syndrome. In: Vishwanath D, Inston N editors. Endocrinology Management 3ed. New York: Edorium Journals; 2012. p. 26-31.
Suggested Reading
The items included in the section of "Suggested Reading" will give readers more resources to refer to than just those given in the "References". These resources although necessary for planning and performing the study, and writing the manuscript are perhaps not directly relevant to the study to be cited in the "References" section.
Include references to articles, abstracts, books, manuals, webpages, videos, presentations or any other material you have referred to in planning and writing your study which are either not directly relevant to your study or not important enough to be cited in the text and given in the "References" section.
Any number of items can be included in this section but we suggest you to limit the number to 15 or less.
The section of "Suggested Reading" will be placed after the "References" section and will be the last section of the article.
Please DO NOT cite the items in the "Suggested Reading" section in the text of your manuscript. If it is found that the items in the "Suggested Reading" section are cited in the text of the manuscript, the manuscript will require revision to remove the same.
Tables
Tables should be provided after references and before the graphs/charts. Please follow the following order when preparing the manuscipt: Tables, Graphs/Charts, Figures
The table numbers should be cited at the relevant places in the text in parenthesis after the punctuation mark. E.g. (Table 1) or (Tables 1-4) or (Tables 1, 4, 6-8).
Each table should be numbered in the order of first citation in the text, using Arabic numerals, e. g. Table 1.
Each table should appear on a separate page.
A title for every table which summarizes the whole table must be given above the table.
Tables should be self-explanatory and not duplicate the data presented in figures.
Kindly prepare tables using the table function of word processing program like Microsoft Word. Do not use spaces or tabs for making tables.
Charts should be sent as Excel or PowerPoint files.
Place explanations, comments and full form of non-standard abbreviations in footnotes below each table.
If some material has been taken from previously published literature, give the reference at the end of the table caption, and include the citation in the list of references at appropriate places.
For footnotes use superscript lower case letters.
Figure Legends
Figures may include clinical images, radiology images, images of laboratory experiments, instruments etc..
The following file formats are accepted for illustrations: JPG, JPEG, PNG, TIFF, BMP, GIF, PowerPoint
Figure files should have a minimum resolution of 300 pixels per inch (ppi) if in color or halftone, or 1200 ppi if as line art. Digital scanned line drawings should have a minimum resolution of 800 dpi. Digital color files must be saved using CMYK or RGB mode.
Figures should be numbered consecutively according to the order in which they have been first cited in the text.
Make all efforts to preserve the anonymity of the patients. If photographs of an individual is used in which a person can be identified, written informed consent must be obtained and submitted to the Editorial Office.
Mention the figure numbers in the text at the appropriate places in parenthesis before the punctuation marks. E.g. (Figure 1) or (Figures 1A, 2) or (Figures 1A, 1C, 3-4) or (Figures 1-3) or (Figures 1, 4-6)
Do not include images in the main manuscript text file. All figures should be provided as separate files.
Include colored figures wherever possible.
The file name should include the figure number. Label file names as: Figure 1, Figure 2 etc.
Try to keep all images separate. You do not need to combine multiple images into a single image.
If it is necessary to combine multiple figures into one composite figure, figure parts should be denoted on the figure by uppercase letters (A, B, C, etc.). Label each figure in the lower left-hand corner (for Figure 1 (A), label figure as 'A', for Figure 1 (B), label figure as 'B', without quotes). Labels should not include the word 'Figure.' The size of the letters should be large enough to be easily visible in case the figure is reduced in size. Use Arial (sans serif) font to add labels. Keep letters of a consistent size in all the figures. Use font color so that the letters contrast with the background. You can use symbols, arrows or letters in the figures to indicate important areas or parts. Do not put the title of figures or explanations on the figure. Mention them in the figure legends.
Please provide legends for figures, double-spaced, on a separate page in the manuscript, with Arabic numerals corresponding to the figures.
The legends should be included in the manuscript text file immediately following the tables/graphs/charts. If multiple images are combined into one composite figure, place the legends of all images included in the composite figure together under one figure.
Figure legend should begin with the term 'Figure' followed by figure number (e.g. 'Figure 1').
Give a good description of the figures. When arrows, symbols or letters are used to identify parts of a figure, identify and explain each one in the legend. Give the magnification and identify the method of staining in photomicrographs.
Do not use any abbreviations unless their full forms are given (excluding common abbreviations such as names of antibodies).
If any person is identifiable in a photograph, written permission must be taken form the subjects(s). Please submit a copy of the permission letter at the time of submitting the Author Agreement Form.
The Journal reserves the right to modify, crop, rotate, reduce, or enlarge the photographs to an acceptable size.
If a figure has been published elsewhere, you will have to submit written permission from the copyright holder to reproduce the material at the time of submitting the Author Agreement Form.
If you include text or figures that have been published elsewhere, you must obtain permission from the copyright owner(s). All expenses for obtaining such permission will have to be paid by the author(s). If you are unable to pay for obtaining permission to use previously published work, we suggest that you use other work available free to refer and cite in your manuscript.
Guidelines for Videos
Authors are invited and encouragde to submit videos as part of the manuscript to increase the understandability and impact of the article. The videos can show new techniques, new application of old technique, procedure, data, discussion, clinical features, diagnostic tests, animated flow diagrams etc.
Types of Videos
A very wide variety of videos are accepted. Some examples of video(s) which may be submitted with the manuscript are:
Procedures (e.g. surgical procedures)
Biomedical tests (e.g. endoscopy, angiography)
Patient's clinical features, lesions
Laboratory Experiments (e.g. methods, results)
Microscopic study
Protocols
Events
Author(s) explaining data/event/procedure/part of manuscript
Author(s) summarizing or commenting on the study
Animated videos showing flowcharts, pathways, procedures
Discussion between authors
Slideshows as video files
Video Resolution
Submit a high resolution video (minimum 800x600px; preferred 1024x768px; excellent 1280x720px or above)
Video Formats
The acceptable video formats are: .avi .divx .flv .mpg .mov .mp4 .wmv
Number of Video Files
Authors have the option of submitting upto 5 video files. The manuscript can also include separate tables, graphs and figures with appropriate legends.
Video File Size
Each single video file must be less than 250Mb. If multiple video files are submitted each file can be of 250Mb or less.
Total combined file size of all submitted video files should be less than 1000Mb (1 Gigabyte).
How to Submit Videos
Videos can be submitted along with the Cover Letter and manuscript text file at the time of submitting the files through the online webform of the journal. When submitting the manuscript files including the video, please be patient as it may take some time for video to upload from your computer/laptop to our server.
To submit large files, use video compression software to compress the files before submitting.
If compression is not possible, please contact the Editorial Office about the procedure to submit large sized videos or high definition video files.
Video Editing Assistance by Editorial Office
Editing videos requires professional technical expertise and specialized software. If authors do not have access to technical expertise or want the Editorial Office to do the video editing, the technical team of the journal can provide video editing services. Authors can get the following assistance in video editing from the Editorial Office. These services are charged separately from Article Processing Charges.
Add a title page to the video
Cut non-essential parts from the video
Add marks/annotation to videos
Improve video parameter like brightness, contrast, aspect ratio etc.
Add subtitles from script provided by authors
Write the script from video and add subtitles from the script
Narration & voiceover from script provided by authors
Write the script from video and add narration & voiceover
Release Form for Human Participants
If human subjects (patients or any other individual) are shown in video/involved in research, authors must take written informed consent from all the subjects in a "Release Form". Have separate "Release Form" signed by all authors/patients/individuals shown in the video. If authors themselves are present in the video, then also a release form (one form for all authors) will be required. The release form MUST be submitted when submitting the manuscript and video files for publication. You may use your own format for the Release Form. If it is not possible to obtain a Release Form for any reason, the identifying features of human participants (e.g. face) must be blurred in the video so that the participants cannot be recognized.
Important Considerations
Use only a good quality video camera or still cameras with video recording facility to record the videos.
Video can be submitted as a single file or as multiple files (maximum five files).
Submit a high resolution video (minimum 800x600px; preferred 1024x768px; excellent 1280x720px or above).
Acceptable video formats: .avi .divx .flv .mpg .mov .mp4 .wmv
Each single video file must be less than 250Mb. If multiple video files are submitted each file can be of 250Mb or less.
Total combined file size of all submitted video files should be less than 1000Mb (1 Gigabyte).
To submit large files, use video compression software to compress the files before submitting. (e.g. Software 1 (Free), Software 2 (Free), Software 3 (Paid), Software 4 (Paid)).
If compression is not possible, please contact the Editorial Office about the procedure to submit large sized/high definition video files.
For detailed description of guidelines for videos, click here
